ISHARES TR - GENOMICS IMMUN (IDNA)

Historical Portfolio Holders from Q1 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / GENOMICS IMMUN
Shares, excl. options Q3 2024
1.68M
Holdings value Q3 2024
$41.3M
Value change Q3 2024
-$5.49M
Grand Portfolio weight change Q3 2024
0%
Number of holders
51
Number of buys Q3 2024
13
Number of sells Q3 2024
-32
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.68M $41.3M -$5.49M $24.61 51
2024 Q2 1.95M $45.1M +$1.99M $23.12 61
2024 Q1 1.86M $44.8M -$3.7M $24.08 61
2023 Q4 1.95M $44.9M +$5.22M $23.01 63
2023 Q3 1.72M $35M -$5.82M $20.35 62
2023 Q2 2.01M $46.9M +$585K $23.35 64
2023 Q1 2.03M $47.2M +$3.4M $23.27 72
2022 Q4 1.84M $46.2M +$1M $25.17 74
2022 Q3 1.78M $46.9M -$4.06M $26.39 63
2022 Q2 1.91M $55.2M -$8.6M $28.90 65
2022 Q1 2.13M $73.3M -$22.1M $34.45 78
2021 Q4 2.6M $115M +$23.2M $43.81 100
2021 Q3 2.04M $104M +$8.42M $50.71 85
2021 Q2 1.89M $98.2M +$1.11M $52.03 81
2021 Q1 1.87M $90M +$20.2M $45.71 76
2020 Q4 1.43M $70M +$15.6M $45.94 62
2020 Q3 1.11M $47.2M +$4.6M $38.96 46
2020 Q2 617K $23.4M +$13.5M $37.96 33
2020 Q1 538K $14.5M -$5.32M $26.87 9
2019 Q4 743K $22.3M -$2.52M $30.00 5
2019 Q3 827K $20.5M +$14.3M $29.41 3
2019 Q2 239K $6.68M +$6.32M $27.17 4
2019 Q1 6.9K $359K $0 $52.03 1